Study of serum miR-518 and its correlation with inflammatory factors in patients with gestational diabetes mellitus complicated with hypertensive disorder complicating pregnancy.

[1]  M. Laan,et al.  Coordinated Expressional Landscape of the Human Placental miRNome and Transcriptome , 2021, Frontiers in Cell and Developmental Biology.

[2]  A. Mousa,et al.  Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence , 2021, International journal of molecular sciences.

[3]  Xu Ma,et al.  Down-regulation of microRNA-30d-5p is associated with gestational diabetes mellitus by targeting RAB8A. , 2021, Journal of diabetes and its complications.

[4]  D. Darmochwal-Kolarz,et al.  Epigenetic Modifications Associated with Exposure to Endocrine Disrupting Chemicals in Patients with Gestational Diabetes Mellitus , 2021, International journal of molecular sciences.

[5]  Shanshan Tang,et al.  Changes of Serum Sex Hormone-Binding Globulin, Homocysteine, and Hypersensitive CRP Levels during Pregnancy and Their Relationship with Gestational Diabetes Mellitus , 2021, Gynecologic and Obstetric Investigation.

[6]  Xiaoni Ma,et al.  miR-875-5p regulates IR and inflammation via targeting TXNRD1 in gestational diabetes rats , 2021, Molecular medicine reports.

[7]  Lei Chen,et al.  Associations between insulin resistance and adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective study , 2021, BMC Pregnancy and Childbirth.

[8]  Xuehong Zhang,et al.  Effect of chromium supplementation on hs-CRP, TNF-α and IL-6 as risk factor for cardiovascular diseases: A meta-analysis of randomized-controlled trials. , 2020, Complementary therapies in clinical practice.

[9]  Xiao Xiao,et al.  Silenced microRNA-222 suppresses inflammatory response in gestational diabetes mellitus mice by promoting CXCR4. , 2020, Life sciences.

[10]  Xuemin Liu,et al.  Regulation and Mechanism of miR-518d through the PPARα-Mediated NF-κB Pathway in the Development of Gestational Diabetes Mellitus , 2020, Journal of diabetes research.

[11]  V. Boussiotis,et al.  The role of Peroxisome Proliferator-Activated Receptors (PPAR) in immune responses. , 2020, Metabolism: clinical and experimental.

[12]  Hanan A Badr,et al.  Risk factors associated with gestational diabetes mellitus: The role of pregnancy-induced hypertension and physical inactivity. , 2020, Pregnancy hypertension.

[13]  H. Metoki,et al.  Epidemiological studies regarding hypertensive disorders of pregnancy: A review , 2020, The journal of obstetrics and gynaecology research.

[14]  P. Antsaklis,et al.  Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial , 2020, Trials.

[15]  E. Alejandro,et al.  Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes , 2020, International journal of molecular sciences.

[16]  Qingju Wang,et al.  Changes of Serum Adiponectin and Glycated Albumin Levels in Gestational Diabetes Mellitus Patients and Their Relationship with Insulin Resistance , 2020, Iranian journal of public health.

[17]  Chun Wang,et al.  Comparison of the expression levels of TNF-α, IL-6, hsCRP and sICAM-1 inflammatory factors, bone mineral density and nutritional status between diabetic and normal pregnant women. , 2020, Cellular and molecular biology.

[18]  D. Fornes,et al.  An extra virgin olive oil‐enriched diet improves maternal, placental, and cord blood parameters in GDM pregnancies , 2020, Diabetes/metabolism research and reviews.

[19]  J. Strosznajder,et al.  The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative Disorders , 2020, Neurochemical Research.

[20]  R. Košir,et al.  Placenta-specific plasma miR518b is a potential biomarker for preeclampsia. , 2020, Clinical biochemistry.

[21]  B. Karwowski,et al.  8-Oxo-7,8-Dihydro-2′-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development , 2020, Molecules.

[22]  Lin Wang,et al.  TLR4/NF-κB Signaling Pathway Participates in the Protective Effects of Apocynin on Gestational Diabetes Mellitus Induced Placental Oxidative Stress and Inflammation , 2020, Reproductive Sciences.

[23]  M. Foti,et al.  Deciphering miRNAs’ Action through miRNA Editing , 2019, International journal of molecular sciences.

[24]  A. Martín-Montalvo,et al.  Molecular Modelling of Islet β-Cell Adaptation to Inflammation in Pregnancy and Gestational Diabetes Mellitus , 2019, International journal of molecular sciences.

[25]  S. Meaney,et al.  The maternal and perinatal implications of hypertensive disorders of pregnancy in a multiple pregnancy cohort , 2019, Acta obstetricia et gynecologica Scandinavica.

[26]  Xiao-Nan Liu,et al.  MicroRNA‐351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus , 2019, Journal of cellular and molecular medicine.

[27]  L. Benschop,et al.  Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy , 2019, Heart.

[28]  C. Gyamfi‐Bannerman,et al.  Hypertensive disorders of pregnancy in twin gestations complicated by gestational diabetes* , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[29]  Kristin Ashford,et al.  Determining Whether Hypertensive Status and Stress Level Are Associated With Inflammatory Markers , 2019, Biological research for nursing.

[30]  Sun Young Park,et al.  Role of Corin in Blood Pressure Regulation in Normotensive and Hypertensive Pregnancy: A Prospective Study , 2019, Hypertension.

[31]  Hong-Yan Zhang,et al.  Correlation analysis of levels of inflammatory cytokines and nitric oxide in peripheral blood with urine proteins and renal function in patients with gestational hypertension , 2018, Experimental and therapeutic medicine.

[32]  Zengfang Wang,et al.  Dysregulation of microRNA‐657 influences inflammatory response via targeting interleukin‐37 in gestational diabetes mellitus , 2018, Journal of cellular physiology.

[33]  M. van den Berge,et al.  Role of microRNAs and exosomes in asthma , 2019, Current opinion in pulmonary medicine.

[34]  K. Baek,et al.  Blood concentrations of lipopolysaccharide-binding protein, high-sensitivity C-reactive protein, tumor necrosis factor-α, and Interleukin-6 in relation to insulin resistance in young adolescents. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[35]  Weijing Zhao,et al.  Heterogeneity of insulin resistance and beta cell dysfunction in gestational diabetes mellitus: a prospective cohort study of perinatal outcomes , 2018, Journal of Translational Medicine.

[36]  D. Ray,et al.  Molecular Actions of PPARα in Lipid Metabolism and Inflammation. , 2018, Endocrine reviews.

[37]  Yangyu Zhao,et al.  miR-518b Enhances Human Trophoblast Cell Proliferation Through Targeting Rap1b and Activating Ras-MAPK Signal , 2018, Front. Endocrinol..

[38]  Xiaohui Song,et al.  Correlation between PPAR-α methylation level in peripheral blood and inflammatory factors of NAFLD patients with DM , 2017, Experimental and therapeutic medicine.

[39]  Hayam Ibrahim Gad Allam,et al.  The Potential Therapeutic Role of Peroxisome ProliferatorActivated Receptors Agonist in Preeclamptic Pregnant Rats. , 2018, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[40]  Gao Yu,et al.  Gestational diabetes mellitus is associated with decreased adipose and placenta peroxisome proliferator-activator receptor γ expression in a Chinese population. , 2017 .

[41]  B. Nagy,et al.  Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension. , 2017, Pregnancy hypertension.

[42]  D. Agrawal,et al.  MicroRNAs associated with inflammation in shoulder tendinopathy and glenohumeral arthritis , 2017, Molecular and Cellular Biochemistry.

[43]  J. Chan,et al.  PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic Syndrome , 2015, International journal of molecular sciences.

[44]  F. Chen,et al.  Deregulated microRNA species in the plasma and placenta of patients with preeclampsia. , 2015, Molecular medicine reports.

[45]  Hui Peng,et al.  Expression of miRNA-1233 in placenta from patients with hypertensive disorder complicating pregnancy and its role in disease pathogenesis. , 2015, International journal of clinical and experimental medicine.

[46]  R. Jia,et al.  DNA Methylation Profiles in Placenta and Its Association with Gestational Diabetes Mellitus , 2015, Experimental and Clinical Endocrinology & Diabetes (Barth).

[47]  Chun Zhao,et al.  MicroRNA-518d regulates PPARα protein expression in the placentas of females with gestational diabetes mellitus. , 2014, Molecular medicine reports.

[48]  Yong Peng,et al.  [Expression of peroxisome proliferator-activated receptor alpha and beta in peripheral blood mononuclear cells of non-vavular hypertensive atrial fibrillation patients]. , 2013, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[49]  J. Kingdom,et al.  Evidence Implicating Peroxisome Proliferator-Activated Receptor-&ggr; in the Pathogenesis of Preeclampsia , 2011, Hypertension.

[50]  M. Shyu,et al.  Hypoxia-mediated down-regulation of OCTN2 and PPARα expression in human placentas and in BeWo cells. , 2011, Molecular pharmaceutics.

[51]  P. Arck,et al.  Nuclear Receptors of the Peroxisome Proliferator-Activated Receptor (PPAR) Family in Gestational Diabetes: From Animal Models to Clinical Trials1 , 2010, Biology of reproduction.